×
GETINGE Operating Expenses 2016-2024 | GNGBY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
GETINGE operating expenses from 2016 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
View More
GETINGE Operating Expenses 2016-2024 | GNGBY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
GETINGE operating expenses from 2016 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$160.9B
Elevance Health (ELV)
$91.8B
Cencora (COR)
$49.1B
Natera (NTRA)
$23.4B
DiDi Global (DIDIY)
$22.6B
ICON (ICLR)
$16.4B
Revvity (RVTY)
$15.4B
Avantor (AVTR)
$15.2B
BioMerieux (BMXMF)
$14.4B
Viatris (VTRS)
$13.5B
CochLear (CHEOY)
$13B
Solventum (SOLV)
$12.8B
Doximity (DOCS)
$11B
Medpace Holdings (MEDP)
$10.9B
EUROFINS SCIENT (ERFSF)
$10.4B
HealthEquity (HQY)
$9.6B
Charles River Laboratories (CRL)
$8.4B
Sonic Healthcare (SKHHY)
$8.3B
Amplifon S.p.A (AMFPF)
$6.1B
Bausch + Lomb (BLCO)
$6.1B
BrightSpring Health Services (BTSG)
$4.1B
Organon (OGN)
$4B
Sotera Health (SHC)
$3.9B
Surgery Partners (SGRY)
$3.2B
Concentras Parent (CON)
$3B
Alignment Healthcare (ALHC)
$3B
PACS (PACS)
$2.2B
Premier (PINC)
$2.2B
Ardent Health Partners (ARDT)
$2.1B
GeneDx Holdings (WGS)
$2.1B